FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989722248> ?p ?o ?g. }

• W2989722248 endingPage "65" @default.
• W2989722248 startingPage "59" @default.
• W2989722248 abstract "Abstract Introduction The Infectious Disease Clinical Research Program’s (IDCRP) Emerging Infectious Diseases and Antimicrobial Resistance (EIDAR) Research Area is a Department of Defense (DoD) clinical research capability that is responsive and adaptive to emerging infectious disease (EID) threats to US military readiness. Among active-duty and other Military Health System (MHS) beneficiaries, EIDAR research is largely focused on evaluating the incidence, risk factors, and acute- and long-term health effects of military-relevant EIDs, especially those caused by high-consequence pathogens or are responsible for outbreaks among US military populations. The EIDAR efforts also address Force Health Protection concerns associated with antimicrobial resistance and antimicrobial stewardship practices within the MHS. Methods The EIDAR studies utilize the approach of: (1) Preparing for emergent conditions to systematically collect clinical specimens and data and conduct clinical trials to assist the military with a scientifically appropriate response; and (2) Evaluating burden of emergent military-relevant infectious diseases and assessing risks for exposure and development of post-infectious complications and overall impact on military readiness. Results In response to the Ebola virus epidemic in West Africa, the IDCRP partnered with the National Institutes of Health in developing a multicenter, randomized safety and efficacy study of investigational therapeutics in Ebola patients. Subsequently, the EIDAR team developed a protocol to serve as a contingency plan (EpICC-EID) to allow clinical research activities to occur during future outbreaks of viral hemorrhagic fever and severe acute respiratory infections among MHS patients. The EIDAR portfolio recently expanded to include studies to understand exposure risks and impact on military readiness for a diversity of EIDs, such as seroincidence of non-Lyme disease borreliosis and Coccidioides fungal infections among high-risk military populations. The team also launched a new prospective study in response to the recent Zika epidemic to conduct surveillance for Zika and other related viruses among MHS beneficiaries in Puerto Rico. Another new study will prospectively follow U.S. Marines via an online health assessment survey to assess long-term health effects following the largest DoD Shiga Toxin-Producing Escherichia coli outbreak at the U.S. Marine Corps Recruit Depot-San Diego. In cooperation with the Trauma-Related Infections Research Area, the EIDAR Research Area is also involved with the Multidrug-Resistant and Virulent Organisms Trauma Infections Initiative, which is a collaborative effort across DoD laboratories to characterize bacterial and fungal isolates infecting combat-related extremity wounds and link lab findings to clinical outcomes. Furthermore, the EIDAR team has developed an Antimicrobial Resistance and Stewardship Collaborative Clinical Research Consortium, comprised of Infectious Disease and Pharmacy specialists. Conclusions The EIDAR Research Area is responsive to military-relevant infectious disease threats that are also frequently global public health concerns. Several new EIDAR efforts are underway that will provide Combatant Command Surgeons, Infectious Diseases Service Chiefs, and other Force Health Protection stakeholders with epidemiological information to mitigate the impact of EIDs and antimicrobial resistance on the health of U.S. military service members and their dependents." @default.
• W2989722248 created "2019-12-05" @default.
• W2989722248 creator A5010456152 @default.
• W2989722248 creator A5010496694 @default.
• W2989722248 creator A5042620005 @default.
• W2989722248 date "2019-04-20" @default.
• W2989722248 modified "2023-10-17" @default.
• W2989722248 title "Emerging Infectious Diseases and Antimicrobial Resistance (EIDAR)" @default.
• W2989722248 cites W1514083101 @default.
• W2989722248 cites W1548190229 @default.
• W2989722248 cites W1561181013 @default.
• W2989722248 cites W1977738733 @default.
• W2989722248 cites W1982858392 @default.
• W2989722248 cites W2033295615 @default.
• W2989722248 cites W2045493897 @default.
• W2989722248 cites W2052843476 @default.
• W2989722248 cites W2073057576 @default.
• W2989722248 cites W2073697896 @default.
• W2989722248 cites W2095524583 @default.
• W2989722248 cites W2119174959 @default.
• W2989722248 cites W2132783048 @default.
• W2989722248 cites W2137725945 @default.
• W2989722248 cites W2147572243 @default.
• W2989722248 cites W2160360001 @default.
• W2989722248 cites W2161908003 @default.
• W2989722248 cites W2327529204 @default.
• W2989722248 cites W2544612685 @default.
• W2989722248 cites W2564361602 @default.
• W2989722248 cites W2569227257 @default.
• W2989722248 cites W2903439732 @default.
• W2989722248 cites W2914471127 @default.
• W2989722248 cites W4245505926 @default.
• W2989722248 cites W625284824 @default.
• W2989722248 doi "https://doi.org/10.1093/milmed/usz081" @default.
• W2989722248 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6802279" @default.
• W2989722248 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31004432" @default.
• W2989722248 hasPublicationYear "2019" @default.
• W2989722248 type Work @default.
• W2989722248 sameAs 2989722248 @default.
• W2989722248 citedByCount "2" @default.
• W2989722248 countsByYear W29897222482021 @default.
• W2989722248 countsByYear W29897222482022 @default.
• W2989722248 crossrefType "journal-article" @default.
• W2989722248 hasAuthorship W2989722248A5010456152 @default.
• W2989722248 hasAuthorship W2989722248A5010496694 @default.
• W2989722248 hasAuthorship W2989722248A5042620005 @default.
• W2989722248 hasBestOaLocation W29897222481 @default.
• W2989722248 hasConcept C116675565 @default.
• W2989722248 hasConcept C142724271 @default.
• W2989722248 hasConcept C159047783 @default.
• W2989722248 hasConcept C17744445 @default.
• W2989722248 hasConcept C177713679 @default.
• W2989722248 hasConcept C199539241 @default.
• W2989722248 hasConcept C2776040555 @default.
• W2989722248 hasConcept C2779134260 @default.
• W2989722248 hasConcept C3008058167 @default.
• W2989722248 hasConcept C501593827 @default.
• W2989722248 hasConcept C524204448 @default.
• W2989722248 hasConcept C535046627 @default.
• W2989722248 hasConcept C544453697 @default.
• W2989722248 hasConcept C71924100 @default.
• W2989722248 hasConcept C86803240 @default.
• W2989722248 hasConcept C89423630 @default.
• W2989722248 hasConcept C89623803 @default.
• W2989722248 hasConcept C94665300 @default.
• W2989722248 hasConcept C99454951 @default.
• W2989722248 hasConceptScore W2989722248C116675565 @default.
• W2989722248 hasConceptScore W2989722248C142724271 @default.
• W2989722248 hasConceptScore W2989722248C159047783 @default.
• W2989722248 hasConceptScore W2989722248C17744445 @default.
• W2989722248 hasConceptScore W2989722248C177713679 @default.
• W2989722248 hasConceptScore W2989722248C199539241 @default.
• W2989722248 hasConceptScore W2989722248C2776040555 @default.
• W2989722248 hasConceptScore W2989722248C2779134260 @default.
• W2989722248 hasConceptScore W2989722248C3008058167 @default.
• W2989722248 hasConceptScore W2989722248C501593827 @default.
• W2989722248 hasConceptScore W2989722248C524204448 @default.
• W2989722248 hasConceptScore W2989722248C535046627 @default.
• W2989722248 hasConceptScore W2989722248C544453697 @default.
• W2989722248 hasConceptScore W2989722248C71924100 @default.
• W2989722248 hasConceptScore W2989722248C86803240 @default.
• W2989722248 hasConceptScore W2989722248C89423630 @default.
• W2989722248 hasConceptScore W2989722248C89623803 @default.
• W2989722248 hasConceptScore W2989722248C94665300 @default.
• W2989722248 hasConceptScore W2989722248C99454951 @default.
• W2989722248 hasFunder F4320306078 @default.
• W2989722248 hasFunder F4320307611 @default.
• W2989722248 hasFunder F4320332161 @default.
• W2989722248 hasFunder F4320332504 @default.
• W2989722248 hasFunder F4320337355 @default.
• W2989722248 hasIssue "Supplement_2" @default.
• W2989722248 hasLocation W29897222481 @default.
• W2989722248 hasLocation W29897222482 @default.
• W2989722248 hasLocation W29897222483 @default.
• W2989722248 hasOpenAccess W2989722248 @default.
• W2989722248 hasPrimaryLocation W29897222481 @default.
• W2989722248 hasRelatedWork W2029988402 @default.
• W2989722248 hasRelatedWork W2361422501 @default.

• next